Notorious patent toll Lodsys has reportedly settled with its defendant on the eve before the case against the company was scheduled for trial, say reports.
Lodsys sued 55 companies, including Kaspersky Labs, as part of its litigation against technology firms for infringing on patents that allow the retrieval of user feedback from fax machines. Lodsys’ has reportedly made its business through obtaining technology patents and then suing companies that use them, a practice that has given rise to the name “patent troll” to describe such operations.
In a statement on the Kaspersky website, the company says that the other 54 companies have settled with Lodsys, and now Lodsys and Kaspersky Labs have also settled without Kaspersky Labs giving money to Lodsys.
According to reports, Lodsys was suing companies for their use of the fax machine patent as a method to obtain feedback from more modern technologies, such as in-app purchases.
The two-year-old lawsuit was dismissed by the judge with prejudice, say reports; both sides were required to pay their own legal fees.
In its statement, Kaspersky said that the result of the case was that “the troll gave up and ran away with nothing and its tail between its legs.”
Full Content: The Verge
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas